CSIMarket
 
Renovacare Inc   (JANI)
Other Ticker:  
 

Renovacare Inc

Business Description


RenovaCare Inc. is a U.S.-based biotechnology company that focuses on the development and commercialization of innovative technologies in the field of regenerative medicine. The company*s primary objective is to develop and market its patented SkinGun?, a handheld device that uses a patient*s own skin cells to generate new skin for the treatment of burns and wounds.

The SkinGun? technology is a breakthrough in the field of regenerative medicine that offers a potential alternative to traditional skin grafting techniques. Unlike grafting, which involves taking skin from another part of the patient*s body, the SkinGun? uses a process known as CellMist?, where a small sample of the patient*s skin is collected, processed, and sprayed onto the affected area. The skin cells are suspended in a liquid solution that acts as a medium to deliver the cells to the wound without causing any damage or discomfort to the patient.

RenovaCare*s SkinGun? has numerous advantages over traditional skin grafting methods. It significantly reduces the pain, scarring, and healing time associated with grafting procedures. Additionally, the SkinGun? allows for a more precise and uniform application of the skin cells, resulting in faster and more effective healing.

The company has been conducting extensive research and development to further enhance the SkinGun? technology and expand its applications. RenovaCare has been successful in optimizing the SkinGun? to treat a wide range of burns, including severe burns that previously had limited treatment options.

In addition to its focus on burn and wound care, RenovaCare is also working on developing the technology for other applications in the field of regenerative medicine. The company has initiated preclinical research to investigate the potential use of the SkinGun? in treating chronic wounds, such as diabetic ulcers and venous leg ulcers.

RenovaCare has received significant recognition and funding for its innovative technology and research. It has been awarded multiple patents for its SkinGun? technology, solidifying its position as a leader in the field of regenerative medicine.

The company*s management team consists of experienced professionals with strong backgrounds in biotechnology and regenerative medicine. They bring their expertise to drive the commercialization of the SkinGun? technology and ensure its widespread adoption in the medical community.

Overall, RenovaCare Inc. is a pioneering biotechnology company that is revolutionizing the field of regenerative medicine. Through its innovative SkinGun? technology, the company aims to provide patients with a more effective and less painful alternative to traditional skin grafting methods for the treatment of burns and wounds. With ongoing research and development, RenovaCare is likely to expand its applications and contribute to the advancement of regenerative medicine.



View Company Supplier View Company Competition View Company Customers


Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com